HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.

Abstract
We attempted a randomized, double blind trial of placebo vs cyclobenzaprine (Flexeril) in 40 female patients with fibromyalgia from a private rheumatology practice in Maine. Patient reports and physician global assessments indicated that cyclobenzaprine was more effective than placebo in alleviating symptoms of fibromyalgia in a subgroup of patients. However, most patients in the study had more accurate perceptions of drug effects than had been predicted and were able to identify the test drug. How much this awareness contributed to the perceived effectiveness of cyclobenzaprine is unknown.
AuthorsL G Quimby, G M Gratwick, C D Whitney, S R Block
JournalThe Journal of rheumatology. Supplement (J Rheumatol Suppl) Vol. 19 Pg. 140-3 (Nov 1989) ISSN: 0380-0903 [Print] Canada
PMID2481741 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antidepressive Agents, Tricyclic
  • Amitriptyline
  • cyclobenzaprine
Topics
  • Adult
  • Aged
  • Amitriptyline (analogs & derivatives, therapeutic use)
  • Antidepressive Agents, Tricyclic (therapeutic use)
  • Depression (psychology)
  • Fibromyalgia (drug therapy, physiopathology, psychology)
  • Humans
  • Middle Aged
  • Pain Measurement
  • Palliative Care
  • Psychiatric Status Rating Scales
  • Randomized Controlled Trials as Topic
  • Sleep (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: